GHK-Cu - topical or injected? Which actually works?
If your goal is skin (collagen, fine lines, wound healing), topical GHK-Cu is the one with real clinical study support. Loren Pickart's research group first identified GHK-Cu in 1973 and has published 40+ years of work showing topical use improves skin density, collagen production, and wound healing. In a 12-week study (67 women, ages 50-59), GHK-Cu cream twice daily improved skin laxity, firmness, fine lines, and pigmentation. Injected GHK-Cu has much thinner evidence - no published human RCTs. If the goal is skin benefits, topical is the studied path.
- 12-week facial study (67 women, ages 50-59): GHK-Cu cream twice daily improved skin laxity, clarity, firmness, fine lines, wrinkles, pigmentation; increased skin density and thickness
- Collagen production improved in 70% of treated women (vs 50% with vitamin C cream, 40% with retinoic acid)
- Mechanism: GHK-Cu at 1 to 10 nanomolar concentrations stimulates collagen, glycosaminoglycans, proteoglycans; activates lysyl oxidase for collagen/elastin cross-linking
- Skin penetration (Inflammation Research 2010): in vitro human skin GHK-Cu penetrates the stratum corneum; estimated 200 to 250 mcg/cm2 copper systemic availability with topical application
- Injectable GHK-Cu: no published human RCTs; animal studies exist for systemic wound healing
- As of April 2026: injectable GHK-Cu is on the Category 2 list, separate from non-injectable; under PCAC review with timeline before February 2027
Your guided peptide companion.
PRTCL walks beginners through their first peptide with confidence - guided reconstitution, dose calculation, vial tracking, and answers to questions like this one. Built for first-timers, useful for everyone.
- · Guided walkthrough for your first dose
- · Dose calculator that does the math for you
- · Vial inventory and dose log tracking
- · Library of physician-vetted protocols
Free to start. Sign in if you already have an account.